GYEMSZI - MOB

ELďż˝ADďż˝S - Kapcsolódó tételek

101.			Lipopeptide Nanoparticulate Vaccine Candidates for the Induction of Protective Immune Responses
102.			Magyarországra behurcolt fertőző megbetegedések elemzése
103.			Melanomás betegeink magas dózisú interferon kezelése osztályunkon
104.			Merging Science and Patient in Future Drug Development to Enhance Safety and Effectiveness
105.			Merre tartunk... merre visz az utunk?
106.			Metabolomic Characterization of Newest Designer Drugs
107.			A Middle East Respiratory Sindrome-Coronavírus (MERS-CoV) járványügyi jelentősége
108.			Miért van szükség plazmaferezissel gyűjtött plazmára?
109.			mRNA-Lipid Nanoparticle COVID-19 Vaccines: Structure and Stability
110.			A munkahelyi egészségfejlesztési tevékenység rendszerének kialakulása, tervezése és gyakorlata a Magyar Honvédségben
111.			Nano-amorphous Oral Sirolimus Formulation with Improved Exposure and Low Inter-individual Variability
112.			NAT tesztelés tapasztalatai világszerte
113.			A NAT vizsgálatok jelentősége az OVSz konfirmálási algoritmusában
114.			Newest Techniques in the Investigation Procedure of Counterfeit/Illegal Medicinal Products
115.			A nigériai képzés tudás menedzsmentje és gyakorlatialkalmazásának lehetőségei
116.			Novel E3 Ligase Ligand Libraries for Degradation of Proteins Implicated in Malignant Diseases
117.			Novel fluorescent Labelled, Pegylated Prussian Blue Nanoparticles for in vivo Optical Imaging
118.			Novel magnetic Prussian Blue nanoparticles for in vivo T1 MR-imaging
119.			Nutritional intake and body composition in children with inflammatory bowel disease : Oral presentation at the 13th Conference of the Hungarian Medical Association of America ? Hungary Chapter (HMA...
120.			Online information on chia seeds : a systematic content analysis : Oral presentation at the 13th Conference of the Hungarian Medical Association of America ? Hungary Chapter (HMAA-HC) at 30?31 Augu...
121.			Orális antikoaguláns kezelés 2016
122.			Pharmacological Overview of the Drug Candidate BGP-15
123.			Physical Chemical Analysis of Fullerene Aqueous Dispersions
124.			The Place of Science in the "One FIP Strategy"
125.			A plazmaferezis állomások működésének hatásai
126.			A plazmagyűjtés tapasztalatai Németországban
127.			Possible Metabolic Transformation of Pinenes to Ionones
128.			Postpartum female sexual dysfunctions in Hungary: a cross-sectional study : Oral presentation at the 13th Conference of the Hungarian Medical Association of America - Hungary Chapter (HMAA-HC) at 3...
129.			Potential Mechanisms Involved in Sphingosine-1-phosphate Induced Coronary Flow Reduction
130.			Preformulation Studies on Polymeric Nanocapsules
131.			Prodrug Nano-Squalene Bioconjugate Drug Products
132.			Project Orbis - New Regulatory Pathway for Innovative Oncology Therapies
133.			Pszichotikus betegek rehabilitációja nappali ellátásban a koronavírus járvány idején
134.			Regulatory Pathway for Drug-Device Combination Products in US
135.			Regulatory Perspectives - Where We Came from, Where Are We Today, Where Are We Headed?
136.			Regulatory Science Challenges - Encouraging Innovation Through an Adaptive Regulatory System
137.			Regulatory Science in Drug Development
138.			The Relations Between Q3 Measurements, In vitro Release and TCS
139.			Revolutionary Application of 3D-Two-Photon Microscopes for Human Therapy and Drug Research
140.			Rheological Studies of Hydrogels and Liposomal Dispersions: Factors Influencing the Viscoelastic Properties
141.			Same Product Different Regulatory Approach Around the World: Glatiramer Acetate
142.			Some Interactions of the Novel Photoswitchable Compound Phototrexate
143.			Space Chemistry Realization via SpaceMedChem
144.			Space Chemistry, Space Medicinal Chemistry and the SpaceMedChem Consortium - Emerging Tools and Initiatives Towards Advanced Drug Development Methods
145.			Structural Analysis of Human Glycoproteins by Tandem Mass Spectrometry
146.			Study of the Degradation of Human Insulin
147.			Study on 3D Printed Innovative Modified Release Formulation
148.			Study on Drug Release from Oleogel Carriers
149.			Supramolecular Structure and Stability of Nanofibrous Drug Delivery Systems
150.			Synthesis and Characterization of New Hexahydroquinoline Derivatives, In Silico Determination of Their Inhibitory Effects on Transformating Growth Factor Beta (TGF-ß) and Their Effects on Oxidative...

Mind kijelölve: